IFNG and glioblastoma: Immunofluorescence analysis demonstrated that both GL261 and CT2A murine GBM cells responded to treatment with GSK126 and/or GSK126 and IFNγ, to decrease in H3K27me3 without having any detrimental effects on cell growth (Supplementary Figures 2A–C).